BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hung CH, Wang JH, Hu TH, Chen CH, Chang KC, Yen YH, Kuo YH, Tsai MC, Lu SN, Lee CM. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 2010; 16(18): 2265-2271 [PMID: 20458764 DOI: 10.3748/wjg.v16.i18.2265]
URL: https://www.wjgnet.com/1007-9327/full/v16/i18/2265.htm
Number Citing Articles
1
Ik-Rak Jung, Rexford S. Ahima, Sangwon F. Kim. Time-Restricted Feeding Ameliorates Methionine–Choline Deficient Diet-Induced Steatohepatitis in MiceInternational Journal of Molecular Sciences 2024; 25(3): 1390 doi: 10.3390/ijms25031390
2
Guang-Ying Shi, Yu Sun, Xing-Chen Liang, Jing-Dong Xie. Clinical significance of expression of serum insulin-like growth factor-1 in patients with primary liver cancer and diabetes mellitusWorld Chinese Journal of Digestology 2021; 29(5): 236 doi: 10.11569/wcjd.v29.i5.236
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
3
Menghan Zhang, Qi Wang, Gongming Zhang, Guangming Li, Ronghua Jin, Huichun Xing. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristicsFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1360478
4
Shintaro Kuroda, Hirotaka Tashiro, Tsuyoshi Kobayashi, Akihiko Oshita, Hironobu Amano, Hideki Ohdan. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child‐Pugh Class BWorld Journal of Surgery 2011; 35(4): 834 doi: 10.1007/s00268-010-0929-y
5
Toru Arano, Hayato Nakagawa, Ryosuke Tateishi, Hitoshi Ikeda, Koji Uchino, Kenichiro Enooku, Eriko Goto, Ryota Masuzaki, Yoshinari Asaoka, Yuji Kondo, Tadashi Goto, Shuichiro Shiina, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patientsInternational Journal of Cancer 2011; 129(9): 2226 doi: 10.1002/ijc.25861
6
Takumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, Masahiro Sakata, Shuji Sumie, Michio Sata. Insulin resistance and chronic liver diseaseWorld Journal of Hepatology 2011; 3(5): 99-107 doi: 10.4254/wjh.v3.i5.99
7
Anne‐Aurélie Raymond, Joaquim Javary, Osman Breig, Véronique Neaud, Jean Rosenbaum. Reptin regulates insulin‐stimulated Akt phosphorylation in hepatocellular carcinoma via the regulation of SHP‐1/PTPN6Cell Biochemistry and Function 2017; 35(6): 289 doi: 10.1002/cbf.3274
8
Chao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implicationsExpert Review of Anti-infective Therapy 2011; 9(5): 525 doi: 10.1586/eri.11.33
9
Tawhida Y Abdel-Ghaffar, Mostafa M Sira, Suzan El Naghi. Hepatitis C genotype 4: The past, present, and futureWorld Journal of Hepatology 2015; 7(28): 2792-2810 doi: 10.4254/wjh.v7.i28.2792
10
Mary-Anne Doyle, Chrissi Galanakis, Erin Mulvihill, Angela Crawley, Curtis Cooper. Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose ParametersCells 2019; 8(3): 252 doi: 10.3390/cells8030252
11
M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab, M. Romero-Gomez. Use of HOMA-IR in hepatitis CJournal of Viral Hepatitis 2011; 18(10): 675 doi: 10.1111/j.1365-2893.2011.01474.x
12
Mohamed Hassan, Denis Selimovic, Abdelouahid El-Khattouti, Hanan Ghozlan, Youssef Haikel, Ola Abdelkader. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategiesWorld Journal of Experimental Medicine 2012; 2(2): 7-25 doi: 10.5493/wjem.v2.i2.7
13
Violeta B. Popov, Joseph K. Lim. Impact of Insulin-Sensitizing Agents on Risk for Liver Cancer and Liver-Related Death in Diabetic Patients with Compensated Hepatitis C CirrhosisThe Journal of Clinical Endocrinology & Metabolism 2011; 96(8): 2398 doi: 10.1210/jc.2011-1875
14
Jing-Houng Wang, Wei-Feng Li, Chee-Chien Yong, Yueh-Wei Liu, Sheng-Nan Lu, Chih-Chi Wang. Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resectionScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85431-y
15
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targetsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934
16
Chun‐Hsun Yang, Yi‐Chun Chiu, Chih‐Hung Chen, Chien‐Hung Chen, Ming‐Chao Tsai, Seng‐Kee Chuah, Chih‐Hsiung Lee, Tsung‐Hui Hu, Chao‐Hung Hung. Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patientsThe Kaohsiung Journal of Medical Sciences 2014; 30(10): 515 doi: 10.1016/j.kjms.2014.06.002
17
Livia M Villar, Cristiane A Villela-Nogueira, Allan P da Silva, Letícia P Scalioni. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.77387
18
Naoki Yoshida, Yutaka Midorikawa, Tokio Higaki, Hisashi Nakayama, Shingo Tsuji, Shunichi Matsuoka, Hisamitsu Ishihara, Mitsuhiko Moriyama, Tadatoshi Takayama. Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus‐related hepatocellular carcinomaHepatology Research 2018; 48(1): 28 doi: 10.1111/hepr.12888
19
Mary-Anne Doyle, Joel Singer, Terry Lee, Miriam Muir, Curtis Cooper. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trialTrials 2016; 17(1) doi: 10.1186/s13063-016-1454-6
20
Inas El Khedr Mohamed, Hany Samir Rasmy, Wagih Abd Elwahab Aly. Evaluation of serum resistin levels in patients with hepatocellular carcinoma before and after treatmentEgyptian Liver Journal 2018; 8(2): 61 doi: 10.1097/01.ELX.0000546516.15821.c2
21
Sherif Mogawer, Mona Mansour, Mohamed Marie, Mervat El-Ansary, Samah Abd El-Hamid. Insulin resistance: a predictor for response to interferon-based therapy in Egyptian patients with chronic HCV genotype 4Comparative Clinical Pathology 2014; 23(1): 7 doi: 10.1007/s00580-012-1560-0
22
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting AntiviralsCancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
23
Anne-Claire Desbois, Patrice Cacoub. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary reviewWorld Journal of Gastroenterology 2017; 23(9): 1697-1711 doi: 10.3748/wjg.v23.i9.1697
24
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open questionWorld Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
25
Sooyeon Oh, Jooho Lee. Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinomaClinical and Molecular Hepatology 2020; 26(4): 476 doi: 10.3350/cmh.2020.0192
26
Marie Sinclair, Mathis Grossmann, Peter W Angus, Rudolf Hoermann, Penelope Hey, Thomas Scodellaro, Paul J Gow. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver diseaseJournal of Gastroenterology and Hepatology 2016; 31(3): 661 doi: 10.1111/jgh.13182
27
Ganji Purnachandra Nagaraju, Sheik Aliya, Olatunji Boladale Alese. Role of adiponectin in obesity related gastrointestinal carcinogenesisCytokine & Growth Factor Reviews 2015; 26(1): 83 doi: 10.1016/j.cytogfr.2014.06.007
28
K. Hamdy, R. Al Swaff, H. A. Hussein, M. Gamal. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinomaJournal of Endocrinological Investigation 2015; 38(11): 1225 doi: 10.1007/s40618-015-0379-3
29
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer2018;  doi: 10.5772/intechopen.80527
30
Mohamed Magdy Salama, Walaa Ahmed Kabiel, Silvia Shoukry Hana, Ghada Abdelrahman Mohamed. Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patientsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00039-7
31
F. Gelley, G. Zadori, G. Firneisz, L. Wagner, I. Fehervári, Z. Gerlei, J. Fazakas, S. Papai, G. Lengyel, E. Sarvary, B. Nemes. Relationship Between Hepatitis C Virus Recurrence and De Novo Diabetes After Liver Transplantation: The Hungarian ExperienceTransplantation Proceedings 2011; 43(4): 1281 doi: 10.1016/j.transproceed.2011.03.065
32
Marie Sinclair, Mathis Grossmann, Paul J Gow, Peter W Angus. Testosterone in men with advanced liver disease: Abnormalities and implicationsJournal of Gastroenterology and Hepatology 2015; 30(2): 244 doi: 10.1111/jgh.12695
33
Fumiaki Konishi, Teruki Miyake, Takao Watanabe, Yoshio Tokumoto, Shinya Furukawa, Bunzo Matsuura, Osamu Yoshida, Masumi Miyazaki, Akihito Shiomi, Sayaka Kanzaki, Hironobu Nakaguchi, Yoshiko Nakamura, Yusuke Imai, Mitsuhito Koizumi, Yasunori Yamamoto, Yohei Koizumi, Masashi Hirooka, Eiji Takeshita, Teru Kumagi, Yoshio Ikeda, Masanori Abe, Yoichi Hiasa. Association of abnormal glucose tolerance with liver‐related disease and cardiovascular diseases in patients with chronic hepatitis CHepatology Research 2023; 53(9): 806 doi: 10.1111/hepr.13925
34
Herbert Tilg, Alexander R. Moschen. Mechanisms behind the link between obesity and gastrointestinal cancersBest Practice & Research Clinical Gastroenterology 2014; 28(4): 599 doi: 10.1016/j.bpg.2014.07.006
35
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVWorld Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
36
Marin E. Healy, Sujoy Lahiri, Stefan R. Hargett, Jenny D.Y. Chow, Frances L. Byrne, David S. Breen, Brandon M. Kenwood, Evan P. Taddeo, Carolin Lackner, Stephen H. Caldwell, Kyle L. Hoehn. Dietary sugar intake increases liver tumor incidence in female miceScientific Reports 2016; 6(1) doi: 10.1038/srep22292
37
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, Michele Vacca. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactionsJournal of Hepatology 2022; 77(1): 219 doi: 10.1016/j.jhep.2022.01.029
38
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCCHepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
39
Shinji Iwane, Toshihiko Mizuta, Yasunori Kawaguchi, Hirokazu Takahashi, Noriko Oza, Satoshi Oeda, Shunya Nakashita, Takuya Kuwashiro, Taiga Otsuka, Seiji Kawazoe, Yuichiro Eguchi, Keizo Anzai, Iwata Ozaki, Kazuma Fujimoto. Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot TrialInternal Medicine 2015; 54(24): 3113 doi: 10.2169/internalmedicine.54.5574
40
Takashi Himoto, Takako Nomura, Joji Tani, Hisaaki Miyoshi, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba, Hisashi Masugata, Tsutomu Masaki. Exacerbation of Insulin Resistance and Hepatic Steatosis Deriving from Zinc Deficiency in Patients with HCV-Related Chronic Liver DiseaseBiological Trace Element Research 2015; 163(1-2): 81 doi: 10.1007/s12011-014-0177-3
41
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and BackTumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
42
Yoshinao Kobayashi, Motoh Iwasa, Hirohide Miyachi, Ryosuke Sugimoto, Hideaki Tanaka, Rumi Mifuji-Moroka, Naoki Fujita, Yasuhiro Sumida, Yoshiyuki Takei. Effect of Iron-Mediated Oxidative Stress on Insulin Resistance Through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis CInternational Journal of Clinical Medicine 2013; 4(01): 10 doi: 10.4236/ijcm.2013.41004
43
Wei-feng Shan, Bing-quan Chen, Shao-jun Zhu, Li Jiang, Yan-feng Zhou. Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosisJournal of Zhejiang University SCIENCE B 2011; 12(8): 677 doi: 10.1631/jzus.B1100001
44
Marie Sinclair, Paul J. Gow, Mathis Grossmann, Adam Shannon, Rudolf Hoermann, Peter W. Angus. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end‐stage liver disease scoreLiver Transplantation 2016; 22(11): 1482 doi: 10.1002/lt.24607
45
Mary-Anne Doyle, Terry Lee, Joel Singer, Angela Crawley, Marina Klein, Curtis Cooper. Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV CoinfectionOpen Forum Infectious Diseases 2019; 6(7) doi: 10.1093/ofid/ofz318
46
Kazuhisa Kaneda, Takahiro Uenishi, Shigekazu Takemura, Hiroji Shinkawa, Yorihisa Urata, Masayuki Sakae, Takatsugu Yamamoto, Shoji Kubo. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinomaJournal of Surgical Oncology 2012; 105(6): 606 doi: 10.1002/jso.22137
47
Dominique Salmon, Firouzé Bani-Sadr, Marc-Arthur Loko, Hind Stitou, Anne Gervais, Jacques Durant, Eric Rosenthal, Yann Quertainmont, Karl Barange, Daniel Vittecoq, Michka Shoai-Tehrani, Muriel Alvarez, Maria Winnock, Jean Claude Trinchet, François Dabis, Philippe Sogni. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIHJournal of Hepatology 2012; 56(4): 862 doi: 10.1016/j.jhep.2011.11.009
48
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)International Journal of Oncology 2012; 41(6): 1919 doi: 10.3892/ijo.2012.1666
49
Chung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, Pei-Chien Tsai, Yu-Min Ko, Kuan-Yu Chen, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyMedicine 2016; 95(27): e4157 doi: 10.1097/MD.0000000000004157
50
Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinomaVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-496
51
Zeynel Abidin Ozturk, Abdurrahman Kadayifci. Insulin sensitizers for the treatment of non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(4): 199-206 doi: 10.4254/wjh.v6.i4.199
52
Beatriz Mateos-Muñoz, Elena García-Martín, María J. Torrejón, María J. Devesa-Medina, Gara Esguevillas, María C. Cárdenas, Cristina Fernández, Miguel Carballo, José A. Agúndez, José M. Ladero. GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis CMedicine 2016; 95(10): e3019 doi: 10.1097/MD.0000000000003019
53
Pierre Deltenre, Alexandre Louvet, Maud Lemoine, Abbas Mourad, Laetitia Fartoux, Christophe Moreno, Jean Henrion, Philippe Mathurin, Lawrence Serfaty. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysisJournal of Hepatology 2011; 55(6): 1187 doi: 10.1016/j.jhep.2011.03.010
54
Toru Arano, Hayato Nakagawa, Hitoshi Ikeda, Kazuhiko Koike. Adiponectin in chronic hepatitis CClinical Journal of Gastroenterology 2013; 6(4): 259 doi: 10.1007/s12328-013-0410-1
55
A. A. Butt, T. Umbleja, J. W. Andersen, K. E. Sherman, R. T. Chung. Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV-Coinfected Persons: The AIDS Clinical Trials Group A5178 StudyClinical Infectious Diseases 2012; 55(5): 631 doi: 10.1093/cid/cis463
56
Omar T. Sims, David E. Pollio, Barry A. Hong, Carol S. North. Racial Disparities in Hepatitis C Treatment EligibilityAnnals of Hepatology 2017; 16(4): 530 doi: 10.5604/01.3001.0010.0282
57
Mariana Lazo, Chizoba Nwankwo, Natalie R. Daya, David L. Thomas, Shruti H. Mehta, Stephen Juraschek, Kerry Willis, Elizabeth Selvin. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States PopulationClinical Gastroenterology and Hepatology 2017; 15(12): 1957 doi: 10.1016/j.cgh.2017.04.046
58
Sayoko Sumiyoshi, Terumi Takahara, Kazuto Shibuya, Johji Imura, Akira Noguchi, Kazuto Tajiri, Masami Minemura, Tsutomu Fujii, Kenichi Hirabayashi. Hepatocellular carcinoma in a transplanted donor liver and colon cancer developing in a patient with a complex background: A case reportOncology Letters 2024; 27(4) doi: 10.3892/ol.2024.14301
59
Takashi Himoto, Joji Tani, Hisaaki Miyoshi, Asahiro Morishita, Hirohito Yoneyama, Kazutaka Kurokohchi, Michio Inukai, Hisashi Masugata, Fuminori Goda, Shoichi Senda, Reiji Haba, Masaki Ueno, Genji Yamaoka, Tsutomu Masaki. Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver diseaseDiabetology & Metabolic Syndrome 2013; 5(1) doi: 10.1186/1758-5996-5-51
60
Seyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewClinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(5): 577 doi: 10.1515/cclm-2018-0357
61
Takumi Kawaguchi, Dan Nakano, Takuji Torimura. Alcoholic/Non-Alcoholic Digestive Diseases2019; : 65 doi: 10.1007/978-981-13-1465-0_7
62
Tzu-Min Hung, Cheng-Maw Ho, Yen-Chun Liu, Jia-Ling Lee, Yow-Rong Liao, Yao-Ming Wu, Ming-Chih Ho, Chien-Hung Chen, Hong-Shiee Lai, Po-Huang Lee, Dong-Yan Jin. Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular CarcinomaPLoS ONE 2014; 9(2): e89446 doi: 10.1371/journal.pone.0089446
63
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 DiabetesClinical Diabetes 2020; 38(1): 40 doi: 10.2337/cd18-0112
64
C. Desbois-Mouthon. De la stéatohépatite non alcoolique au carcinome hépatocellulaire : mécanismes physiopathologiquesMédecine des Maladies Métaboliques 2011; 5(1): 38 doi: 10.1016/S1957-2557(11)70184-5
65
Marie Sinclair, Mathis Grossmann, Rudolf Hoermann, Peter W. Angus, Paul J. Gow. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trialJournal of Hepatology 2016; 65(5): 906 doi: 10.1016/j.jhep.2016.06.007
66
Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Wataru Okamoto, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Daiki Miki, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hiroshi Aikata. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year studyBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01884-5
67
Carmela Loguercio, Pietro Andreone, Ciprian Brisc, Michaela Cristina Brisc, Elisabetta Bugianesi, Maria Chiaramonte, Carmela Cursaro, Mirela Danila, Ilario de Sio, Annarosa Floreani, Maria Antonietta Freni, Antonio Grieco, Marzia Groppo, Roberta Lazzari, Salvatore Lobello, Elisabetta Lorefice, Marzia Margotti, Luca Miele, Stefano Milani, Lajos Okolicsanyi, Giuseppe Palasciano, Piero Portincasa, Patrizia Saltarelli, Antonina Smedile, Francesco Somalvico, Aldo Spadaro, Ioan Sporea, Paolo Sorrentino, Raffaela Vecchione, Concetta Tuccillo, Camillo Del Vecchio Blanco, Alessandro Federico. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trialFree Radical Biology and Medicine 2012; 52(9): 1658 doi: 10.1016/j.freeradbiomed.2012.02.008
68
Takashi Oono, Takahiro Yamasaki, Junichi Zaitsu, Issei Saeki, Takuya Iwamoto, Yumiko Harima, Yoshio Marumoto, Isao Hidaka, Yohei Urata, Tsuyoshi Ishikawa, Taro Takami, Makoto Segawa, Koichi Uchida, Shuji Terai, Ichiro Kunitugu, Tsuyoshi Tanabe, Isao Sakaida. Association of tyrosine with insulin resistance in hepatitis C virus‐related chronic liver diseaseHepatology Research 2014; 44(10) doi: 10.1111/hepr.12213
69
M. Sinclair, P. J. Gow, M. Grossmann, P. W. Angus. Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventionsAlimentary Pharmacology & Therapeutics 2016; 43(7): 765 doi: 10.1111/apt.13549
70
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future PerspectivesJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00002
71
Carolina M. Pusec, Vladimir Ilievski, Adam De Jesus, Zeenat Farooq, Joseph L. Zapater, Nadia Sweis, Hagar Ismail, Md Wasim Khan, Hossein Ardehali, Jose Cordoba-Chacon, Brian T. Layden. Liver-specific overexpression of HKDC1 increases hepatocyte size and proliferative capacityScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33924-3
72
Areeba Rehman, Maria Shabbir, Yasmin Badshah, Khushbukhat Khan, Janeen H. Trembley, Naeem Mahmood Ashraf, Tayyaba Afsar, Ali Almajwal, Nawaf W. Alruwaili, Ali Alshamari, Tariq Nahar Alanezi, Suhail Razak. Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinomaBMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10618-7
73
Nicolas Goossens, Sophie Clément, Francesco Negro. Handbook of Hepatitis C2016; : 33 doi: 10.1007/978-3-319-28053-0_4
74
Anil C. Anand. Nutrition and Muscle in CirrhosisJournal of Clinical and Experimental Hepatology 2017; 7(4): 340 doi: 10.1016/j.jceh.2017.11.001
75
Vincenzo Boccaccio, Savino Bruno. Optimal management of patients with chronic hepatitis C and comorbiditiesLiver International 2015; 35(s1): 35 doi: 10.1111/liv.12712
76
Jinyan Zhao, Yunpeng Zhao, Hao Wang, Xing Gu, Jun Ji, Chunfang Gao. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional studyNutrition Journal 2011; 10(1) doi: 10.1186/1475-2891-10-49
77
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinomaLiver International 2015; 35(10): 2203 doi: 10.1111/liv.12903
78
Mary-Anne Doyle, Curtis Cooper. Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case ReportAmerican Journal of Case Reports 2015; 16: 745 doi: 10.12659/AJCR.895064
79
Engy Yousry Elsayed, Nesreen Ahmed Mosalam, Noha Refaat Mohamed. Resistin and Insulin Resistance: A Link Between Inflammation and HepatocarcinogenesisAsian Pacific Journal of Cancer Prevention 2015; 16(16): 7139 doi: 10.7314/APJCP.2015.16.16.7139
80
Krasimira Aleksandrova, Heiner Boeing, Ute Nöthlings, Mazda Jenab, Veronika Fedirko, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Dimitrios Trichopoulos, Paolo Boffetta, Elisabeth Trepo, Sabine Westhpal, Talita Duarte‐Salles, Magdalena Stepien, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Marie‐Christine Boutron‐Ruault, Laure Dossus, Antoine Racine, Pagona Lagiou, Christina Bamia, Vassiliki Benetou, Claudia Agnoli, Domenico Palli, Salvatore Panico, Rosario Tumino, Paolo Vineis, Bas Bueno‐de‐Mesquita, Petra H. Peeters, Inger Torhild Gram, Eiliv Lund, Elisabete Weiderpass, J. Ramón Quirós, Antonio Agudo, María‐José Sánchez, Diana Gavrila, Aurelio Barricarte, Miren Dorronsoro, Bodil Ohlsson, Björn Lindkvist, Anders Johansson, Malin Sund, Kay‐Tee Khaw, Nicholas Wareham, Ruth C. Travis, Elio Riboli, Tobias Pischon. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancerHepatology 2014; 60(3): 858 doi: 10.1002/hep.27016
81
Jung Hee Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patientsJournal of Gastroenterology and Hepatology 2017; 32(5): 1100 doi: 10.1111/jgh.13647
82
Ammar Hassan, Elliot B. Tapper. The Critically Ill Cirrhotic Patient2020; : 141 doi: 10.1007/978-3-030-24490-3_9
83
Cheng-Hao Su, Yong Lin, Lin Cai. Genetic Factors, Viral Infection, Other Factors and Liver Cancer: An Update on Current ProgressAsian Pacific Journal of Cancer Prevention 2013; 14(9): 4953 doi: 10.7314/APJCP.2013.14.9.4953
84
Iva Košuta, Anna Mrzljak, Branko Kolarić, Marijana Vučić Lovrenčić. Leptin as a Key Player in Insulin Resistance of Liver Cirrhosis? A Cross-Sectional Study in Liver Transplant CandidatesJournal of Clinical Medicine 2020; 9(2): 560 doi: 10.3390/jcm9020560